Patent US2497080A successfully refreshed from Google Patents.
Patent US6069006A successfully refreshed from Google Patents.
← Back to Patent Explorer
US6069006A Expired / Lapsed US ⏱️ 0.0 years remaining

Connective tissue growth factor (CTGF) regulatory nucleic acid sequences

Assignee: University of South Florida St. Petersburg
•
Filing: 1998-04-02
•
Granted: 2000-05-30
•
Expires: 2018-04-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides a novel polypeptide, Connective Tissue Growth Factor (CTGF), polynucleotides encoding CTGF, and including 5' and 3' untranslated nucleotides, antibodies reactive with CTGF and means for producing CTGF. Also provided are diagnostic and therapeutic methods for using CTGF, as well as an assay for identifying compositions which affect the expression of CTGF polynucleotide. The invention provides a novel TGF- beta responsive element upstream of the polynucleotide encoding CTGF structural gene.

Inventors

  • 👤 Gary R. Grotendorst
  • 👤 Douglass M. Bradham, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 18:34
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/475; A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/18; A61K38/1841; A61K38/39; A61P; A61P11/00; A61P13/00; A61P13/12; A61P17/00; A61P17/02; A61P19/00; A61P19/04; A61P27/00; A61P27/02; A61P27/06; A61P35/00; A61P43/00; A61P9/00; A61P9/10; C12; C12N; C12N5/00; C12N5/06; C12N5/0602; C12N5/0652; C12N5/0655

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 42 words
An isolated polynucleotide comprising 5' untranslated regulatory nucleotide sequences isolated from upstream of a Connective Tissue Growth Factor (CTGF) gene, wherein said regulatory nucleotide sequences comprise a sequence as set forth in SEQ ID NO: 1 from about nucleotides 1 to 897.
Claim 2
Dependent Claim 42 words
An isolated polynucleotide comprising 5' untranslated regulatory nucleotide sequences isolated from upstream of a Connective Tissue Growth Factor (CTGF) gene, wherein said regulatory nucleotide sequences comprise a sequence as set forth in SEQ ID NO: 1 from about nucleotides 1 to 897.
Claim 3
Dependent Claim 18 words
The polynucleotide of claim 1, wherein said untranslated regulatory nucleotide sequences comprises a transcriptional and translational initiation region.
Claim 4
Dependent Claim 20 words
An isolated polynucleotide consisting of the sequence 5'-GTGTCAAGGGGTC-3' (SEQ ID NO: 8), wherein said sequence is a TGF-beta responsive element.
Claim 5
Dependent Claim 20 words
An isolated polynucleotide consisting of the sequence 5'-GTGTCAAGGGGTC-3' (SEQ ID NO: 8), wherein said sequence is a TGF-beta responsive element.
Claim 6
Dependent Claim 18 words
An isolated polynucleotide comprising a TGF-β regulatory element, said element comprising nucleotides 1-698 of SEQ ID NO: 1.
Claim 7
Dependent Claim 18 words
An isolated polynucleotide comprising a TGF-β regulatory element, said element comprising nucleotides 1-698 of SEQ ID NO: 1.
Claim 8
Dependent Claim 14 words
An isolated TGF-β regulatory element, consisting of nucleotides 664-698 of SEQ ID NO: 1.
Claim 9
Dependent Claim 14 words
An isolated TGF-β regulatory element, consisting of nucleotides 664-698 of SEQ ID NO: 1.
Claim 10
Dependent Claim 76 words
An isolated nucleic acid construct comprising a non-coding regulatory sequence isolated upstream from a Connective Tissue Growth Factor (CTGF) gene, wherein said non-coding regulatory sequence is operably associated with a nucleic acid sequence which expresses a protein of interest or antisense RNA, wherein said nucleic acid sequence is heterologous to said non-coding sequence, and wherein the non-coding regulatory sequence comprises a sequence as set forth in SEQ ID NO: 1 from about nucleotides 1 to 897.
Claim 11
Dependent Claim 76 words
An isolated nucleic acid construct comprising a non-coding regulatory sequence isolated upstream from a Connective Tissue Growth Factor (CTGF) gene, wherein said non-coding regulatory sequence is operably associated with a nucleic acid sequence which expresses a protein of interest or antisense RNA, wherein said nucleic acid sequence is heterologous to said non-coding sequence, and wherein the non-coding regulatory sequence comprises a sequence as set forth in SEQ ID NO: 1 from about nucleotides 1 to 897.
Claim 12
Dependent Claim 16 words
The nucleic acid construct of claim 6, wherein said construct is contained in a host cell.

References Cited (Backward Citations)

US5356630A Cited
US5149691A Cited
WO1993000430A1 Cited
US5408040A Cited
US5585270A Cited
US5399361A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2003-05-30 2003-11-29 2004-05-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2007-05-30 2007-11-29 2008-05-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2011-05-30 2011-11-29 2012-05-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag